Modular Sulfonamide Agonists for Orexin Receptor Selectivity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for neurological and psychiatric disorders related to orexin receptors are inadequate, and there is a need for more effective therapeutic approaches targeting these receptors.
Innovation Solution
Development of sulfonamide compounds that act as orexin receptor agonists, which can be used to treat or prevent disorders associated with orexin receptors, including neurological and psychiatric conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for neurological and psychiatric disorders are used, then existing therapeutic options are available, but the treatments are inadequate and lack effectiveness
Solution Approach 1:
The patent applies parameter changes by developing novel sulfonamide compounds with specific chemical structures (formula I) that have optimized binding affinity and selectivity for orexin receptors. By modifying molecular parameters such as substituent groups (R1, R2, R3, R4, R5, R6) and structural features (m, n, p values), the invention creates compounds with enhanced therapeutic effectiveness and receptor specificity, directly addressing the inadequacy of current treatments
Solution Approach 2:
The invention employs composite material principles by creating complex sulfonamide compounds that combine multiple functional groups and structural elements into a single molecular entity. These composite structures (featuring sulfonamide cores with various aromatic rings, alkyl groups, and heteroatoms) enable simultaneous interaction with multiple receptor sites, thereby improving therapeutic reliability while expanding treatment versatility
2Reliability
If sulfonamide compounds are developed as orexin receptor agonists, then therapeutic benefits for various disorders can be achieved, but the complexity of compound structure increases
Solution Approach 1:
The patent applies segmentation by dividing the complex sulfonamide molecule into distinct functional segments: a core sulfonamide group, aromatic ring systems (Ring A), substituent groups (R1-R6), and structural variables (m, n, p). This modular segmentation allows systematic optimization of each component's contribution to receptor binding while managing overall molecular complexity through structured design
Solution Approach 2:
The invention demonstrates universality by designing sulfonamide compounds with multiple functional capabilities within a single molecular structure. The compounds can simultaneously engage in hydrophobic interactions, hydrogen bonding, and electrostatic interactions with orexin receptors, providing multi-functional therapeutic effects that address various disorders (narcolepsy, insomnia, feeding behavior) through a single compound class
Data Source
AI summary
The present invention is directed to compounds of Formula I which are agonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.